Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 12/20 | 0.47 |
| ▸ | NPY1R | P25929 | 8/20 | 0.47 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.47 |
| ▸ | NPY2R | P49146 | 4/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.45 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.45 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29532003 | 0.92 | NPY4R (0.47) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL29689021 | 0.92 | RAMP3 (0.49) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30441875 | 0.90 | NPY4R (0.47) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL30786594 | 0.89 | NPY4R (0.47) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL31621731 | 0.88 | NPY4R (0.52) | NPY4RNPY1RNPY5RNPY2RKEAP1 | |
| SCHEMBL31679147 | 0.88 | NPY5R (0.47) | NPY4RNPY1RNPY5RNPY2RKEAP1 | |
| SCHEMBL26886898 | 0.88 | NPY4R (0.46) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL29464017 | 0.88 | NPY4R (0.52) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL30239265 | 0.87 | NPY4R (0.48) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL30239166 | 0.87 | NPY4R (0.49) | NPY4RNPY1RNPY5RNPY2ROPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117982615-B | Application of polypeptide LLTRAGL in preparation of medicines for preventing and/or treating inflammatory bowel disease | 齐鲁工业大学(山东省科学院) | 2024-10-08 | — | — | CN | disclosed |
| CN-118217381-A | Application of polypeptide LLTRAGL in preparation of drugs for resisting liver injury caused by isoniazid | 齐鲁工业大学(山东省科学院) | 2024-06-21 | — | — | CN | disclosed |
| CN-117982615-A | Application of polypeptide LLTRAGL in preparation of medicines for preventing and/or treating inflammatory bowel disease | 齐鲁工业大学(山东省科学院) | 2024-05-07 | — | — | CN | disclosed |
| CN-111423495-B | Rapana venosa polypeptide with oxidative stress damage resistance and preparation method and application thereof | 山东省科学院生物研究所 | 2022-06-28 | — | — | CN | disclosed |